H. Gralnick

发表

Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group

H. Gralnick, D. Catovsky, J. Bennett, 1976, British journal of haematology.

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.

G Flandrin, C Sultan, D. Catovsky, 1985, Annals of internal medicine.

Proposals for the classification of the myelodysplastic syndromes

H. Gralnick, D. Catovsky, J. Bennett, 1982, British journal of haematology.

Platelet adhesion to collagen types I through VIII under conditions of stasis and flow is mediated by GPIa/IIa (alpha 2 beta 1-integrin).

J. Sixma, P. D. de Groot, H. Gralnick, 1994, Blood.

Heparin-induced thrombocytopenia: confirmation of diagnosis with in vitro methods.

H. Gralnick, J. Fratantoni, R. Pollet, 1975 .

Heparin treatment for the hemorrhagic diathesis of acute promyelocytic leukemia.

H. Gralnick, J. Bagley, E. Abrell, 1972, The American journal of medicine.

Studies on the purification and characterization of human factor VIII

H. Gralnick, S. Marchesi, N. Shulman, 1972 .

Inhibition of platelet-von Willebrand factor binding to platelets by adhesion site peptides.

H. Gralnick, H. Gralnick, R. Parker, 1989, Blood.

Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group.

D. Catovsky, J. Bennett, G. Flandrin, 1985, Annals of internal medicine.

The molecular defect in type IIB von Willebrand disease. Identification of four potential missense mutations within the putative GpIb binding domain.

K. Cooney, H. Gralnick, D. Ginsburg, 1991, The Journal of clinical investigation.

Comparison of polymerization of ancrod and thrombin fibrin monomers.

H. Gralnick, G. Spellman, J. Macoviak, 1977, Blood.

Cold-induced contact surface activation of the prothrombin time in whole blood.

H. Gralnick, R. N. Palmer, 1982, Blood.

Upper Extremity Impedance Plethysmography in Patients with Venous Access Devices

H. Gralnick, H. Alexander, E. Whitman, 1994, Thrombosis and Haemostasis.

Warfarin anticoagulation: difficulties in interpretation of the prothrombin time.

H. Gralnick, C. Kessler, R. N. Palmer, 1982, Thrombosis research.

Misinterpretation of prothrombin time in warfarin anticoagulation.

H. Gralnick, R. N. Palmer, C. Kessler, 1981, Annals of internal medicine.

A variant form of hypergranular promyelocytic leukemia (M3)

H. Gralnick, D. Catovsky, J. Bennett, 1980, Annals of internal medicine.

Energy-dependent expression of platelet-von Willebrand factor on the surface of unstimulated and stimulated platelets.

H. Gralnick, R. Parker, 1997, The Journal of laboratory and clinical medicine.

Effect of aspirin on platelet-von Willebrand factor surface expression on thrombin and ADP-stimulated platelets.

H. Gralnick, R. Parker, 1989, Blood.

Fibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release.

H. Gralnick, J. Finlayson, J. Shainoff, 1971, The Journal of clinical investigation.

Identification of platelet glycoprotein IIb/IIIa as the major binding site for released platelet-von Willebrand factor.

H. Gralnick, R. Parker, 1986, Blood.

Subendothelial matrix of cultured endothelial cells contains fully processed high molecular weight von Willebrand factor.

H. Gralnick, S. Tannenbaum, M. Rick, 1989, The Journal of laboratory and clinical medicine.

Urinary fibrin split products in lupus nephritis. Correlation with other parameters of renal disease.

A. Steinberg, H. Gralnick, S. Marchesi, 1974, Arthritis and rheumatism.

The Effect of Suramin on Laboratory Tests of Coagulation

H. Gralnick, O. Wilson, M. Cooper, 1992, Thrombosis and Haemostasis.

Collagen-factor VIII/von Willebrand factor protein interaction.

H. Gralnick, C. Kessler, M. Rick, 1984, Blood.

Comparison of polymerization of ancrod and thrombin fibrin monomers

H. Gralnick, G. Spellman, J. Macoviak, 1977 .

The oligosaccharide of human thrombin: investigations of functional significance.

H. Gralnick, M. Horne, 1984, Blood.

Influence of factor VIII/von Willebrand factor protein (F VIII/vWF) and F VIII/vWF-poor cryoprecipitate on post-ischemic microvascular reperfusion in the central nervous system.

H. Gralnick, J. Hallenbeck, T. Furlow, 1981, Stroke.

Dominant inheritance of hemophilia A in three generations of women.

H. Gralnick, A. Cederbaum, H. Roberts, 1975, Blood.

Circulating heparan sulfate anticoagulant in a patient with a fatal bleeding disorder.

H. Gralnick, P. D. Rick, R. N. Palmer, 1984, The New England journal of medicine.

Dysfibrinogenemia associated with hepatoma. Increased carbohydrate content of the fibrinogen molecule.

H. Gralnick, H. Gralnick, E. Abrams, 1978, The New England journal of medicine.

Intravascular coagulation in acute leukemia: clinical and subclinical abnormalities.

H. Gralnick, S. Marchesi, H. Givelber, 1972, Blood.

Cold-promoted activation of factor VII and shortening of the prothrombin time.

H. Gralnick, O. Wilson, 1987, Advances in experimental medicine and biology.

The identification and functional significance of factor VIII components on normal platelets.

H. Gralnick, M. Rick, M. Flaum, 1982, Thrombosis Research.

Activated platelets in paroxysmal nocturnal haemoglobinuria

H. Gralnick, H. Gralnick, L. McKeown, 1995, British journal of haematology.

Effect of multimeric structure of the factor VIII/von Willebrand factor protein on binding to platelets.

H. Gralnick, S. Williams, D. Morisato, 1981, Blood.

The carbohydrate of human thrombin: structural analysis of glycoprotein oligosaccharides by mass spectrometry.

H. Gralnick, H. Gralnick, M. Horne, 1983, Archives of biochemistry and biophysics.

Asialo-von Willebrand factor inhibits platelet adherence to human arterial subendothelium: discrepancy between ristocetin cofactor activity and primary hemostatic function

H. Gralnick, J. Lawrence, 1987 .

Heparin-induced thrombocytopenia: confirmation of diagnosis with in vitro methods.

H. Gralnick, J. Fratantoni, R. Pollet, 1975, Blood.

Glycoprotein Ia-IIa (VLA-2) and glycoprotein Ib-IX complexes are processed independently during thrombin-induced platelet activation.

P. Nurden, H. Gralnick, A. Nurden, 1994, The Journal of laboratory and clinical medicine.

in Three Generations of Women

H. Gralnick, A. Cederbaum, H. Roberts, 2017 .

Identification of the thrombin receptor on human platelets by chemical crosslinking.

H. Gralnick, J. Takamatsu, M. Horne, 1986, The Journal of clinical investigation.

Danazol increases factor VIII and factor IX in classic hemophilia and Christmas disease.

H. Gralnick, M. Rick, 1983, The New England journal of medicine.

Immunological studies of factor VIII (antihaemophiliac globulin) in haemophilia A.

H. Gralnick, E. Abrell, J. Eagley, 1971, Nature: New biology.

Asialo-von Willebrand factor inhibits platelet adherence to human arterial subendothelium: discrepancy between ristocetin cofactor activity and primary hemostatic function.

H. Gralnick, H. Gralnick, J. Lawrence, 1987, Blood.

In vitro correction of the abnormal multimeric structure of von Willebrand factor in type IIa von Willebrand's disease.

H. Gralnick, S. Williams, Y. Sultan, 1985, Proceedings of the National Academy of Sciences of the United States of America.

DDAVP in type IIa von Willebrand's disease.

H. Gralnick, S. Williams, Y. Sultan, 1986, Blood.

Factor VIII/von Willebrand factor protein. Galactose a cryptic determinant of von Willebrand factor activity.

H. Gralnick, 1978, The Journal of clinical investigation.

The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia: Proposals by the French ‐ American ‐ British Cooperative Leukaemia Group

H. Gralnick, D. Catovsky, J. Bennett, 1994, British journal of haematology.

A monomeric von Willebrand factor fragment, Leu-504--Lys-728, inhibits von Willebrand factor interaction with glycoprotein Ib-IX [corrected].

H. Gralnick, H. Krutzsch, S. Williams, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Fibrin monomer induces binding of endogenous platelet von Willebrand factor to the glycocalicin portion of platelet glycoprotein IB.

H. Gralnick, R. Parker, 1987, Blood.

Monoclonal antibodies to the glycoprotein IIb-IIIa epitopes involved in adhesive protein binding: effects on platelet spreading and ultrastructure on human arterial subendothelium.

H. Gralnick, J. Lawrence, 1987, The Journal of laboratory and clinical medicine.

Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group.

H. Gralnick, D. Catovsky, J. Bennett, 1989, Journal of clinical pathology.

A New Congenital Abnormality of Human Fibrinogen

H. Gralnick, J. Finlayson, H. Givelber, 1973, Thrombosis and Haemostasis.

Selective binding of the factor VIII/von Willebrand factor protein to human platelets.

H. Gralnick, D. Morisato, 1980, Blood.

Inhibition of cold-promoted activation of the prothrombin time studies of new siliconized borosilicate collection tubes in normals and patients receiving warfarin.

H. Gralnick, R. N. Palmer, 1985, American journal of clinical pathology.

Benefits of danazol treatment in patients with hemophilia A (classic hemophilia).

H. Gralnick, Y. Sultan, M. Rick, 1985, JAMA.

Hypergranular promyelocytic leukemia: correlation between morphology and chromosomal translocations including t(15;17) and t(11;17)

D. Catovsky, G. Flandrin, D. Galton, 2000, Leukemia.

Hematologic manifestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis.

W. Travis, H. Gralnick, D. Metcalfe, 1991, The American journal of medicine.

Influence of Factor VHI/von Willebrand Factor Protein (F VIII/vWF) and F VIII/vWF‐Poor Cryoprecipitate on Post‐ischemic Microvascular Reperfusion in the Central Nervous System

H. Gralnick, J. Hallenbeck, T. Furlow, 1981 .

Platelet Density-Dependent Partition of Platelet- von Willebrand Factor Between Alpha Granule and Non-Alpha Granule Pools

H. Gralnick, R. Parker, B. Shafer, 1987, Thrombosis and Haemostasis.

Effect of calcium on the availability of platelet von Willebrand factor.

H. Gralnick, R. Parker, M. Rick, 1985, Journal of Laboratory and Clinical Medicine.

A method to minimize platelet activation during platelet isolation.

H. Gralnick, R. Parker, M. Rick, 1984, Thrombosis Research.

Inhibition of the cold activation of Factor VII and the prothrombin time.

H. Gralnick, R. N. Palmer, 1984, American Journal of Clinical Pathology.

Inhibition of platelet-von Willebrand factor binding to platelets by adhesion

H. Gralnick, H. Gralnick, R. Parker, 2011 .

Platelet adhesion to cyanogen-bromide fragments of collagen alpha 1(I) under flow conditions.

J. Sixma, P. D. de Groot, H. Gralnick, 1993, Blood.

Thromboplastin Calibration and Oral Anticoagulant Control

S. Lewis, H. Gralnick, A. Besselaar, 1984, Developments in Hematology and Immunology.

Cryoprecipitate transfusion in variant von Willebrand's disease and thrombocytopenia.

H. Gralnick, S. Williams, M. Rick, 1983, Annals of internal medicine.

Joint ICTH/ICSH Proposed Policy Statement with Respect to Reporting the Prothrombin Time in Oral Anticoagulant Control

S. Lewis, H. Gralnick, A. Besselaar, 1984 .

Fibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release.

H. Gralnick, J. Finlayson, J. Shainoff, 1971, The Journal of clinical investigation.

Arginine-glycine-aspartic acid- and fibrinogen gamma-chain carboxyterminal peptides inhibit platelet adherence to arterial subendothelium at high wall shear rates. An effect dissociable from interference with adhesive protein binding.

H. Gralnick, H. Gralnick, S. Williams, 1990, The Journal of clinical investigation.

The Importance of the Carbohydrate Moiety of the Factor VIII/Von Willebrand Factor Protein in Binding to and Causing Agglutination of Human Platelets

H. Gralnick, D. Morisato, 1979, Thrombosis and Haemostasis.